Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitu...
Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
About this item
Full title
Author / Creator
Publisher
Canada: Joule Inc
Journal title
Language
English
Formats
Publication information
Publisher
Canada: Joule Inc
Subjects
More information
Scope and Contents
Contents
AbstractBackgroundMetformin is widely accepted as first-line pharmacotherapy for patients with type 2 diabetes mellitus when glycemic control cannot be achieved by lifestyle interventions alone. However, uncertainty exists regarding the optimal second-line therapy for patients whose diabetes is inadequately controlled by metformin monotherapy. Incr...
Alternative Titles
Full title
Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3216433
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3216433
Other Identifiers
ISSN
0820-3946
E-ISSN
1488-2329
DOI
10.1503/cmaj.110178
